• Explore /
  • Poster
  • / Impact of postoperative complications on recurrence in pathological stage II/III gastric cancer patients who received curative resection followed by adjuvant S-1 chemotherapy.

Impact of postoperative complications on recurrence in pathological stage II/III gastric cancer patients who received curative resection followed by adjuvant S-1 chemotherapy.

Abstract Poster

Authors

null

Hayato Watanabe

Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan

Hayato Watanabe , Tsutomu Hayashi , Keisuke Koumori , Kazuki Kano , Yota Shimoda , Hirohito Fujikawa , Takanobu Yamada , Yasushi Rino , Munetaka Masuda , Takashi Ogata , Takashi Oshima

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 320)

Abstract #

320

Poster Bd #

B17

Abstract Disclosures

Similar Posters

First Author: Chi Hoon Maeng

Poster

2024 ASCO Gastrointestinal Cancers Symposium

A phase II trial of CapeOX plus nivolumab for early relapsed HER2-negative gastric cancer (JACCRO GC-11: FirSTAR trial).

A phase II trial of CapeOX plus nivolumab for early relapsed HER2-negative gastric cancer (JACCRO GC-11: FirSTAR trial).

First Author: Hiroyuki Arai

First Author: Souya Nunobe

First Author: Yoshiaki Iwasaki